Within the psychoneurological armamentarium, relatively few agents can simultaneously calm anxiety and stimulate cognitive function without inducing pronounced sedation and muscle relaxation. Phenibut (international name: aminophenylbutyric acid) is a synthetic derivative of gamma-aminobutyric acid (GABA) and phenylethylamine that merges the properties of an anxiolytic (anti-anxiety agent) and a mild nootropic. A pack of 20 tablets, each containing 250 mg, is designed for course-based therapy under strict medical supervision — self-directed use of this compound is fraught with serious risks.
The uniqueness of phenibut resides in its ability to influence the central nervous system through multiple channels:
A physician may consider prescribing phenibut in the following pathological states:
Fundamental Cautions:
Phenibut intake is absolutely ruled out in the setting of:
Enhanced Caution: is required for patients whose activities involve driving motor vehicles or operating machinery — particularly during the initial days of therapy, until the individual reaction to the drug is clarified.
When therapeutic doses are adhered to, phenibut is well tolerated. Among the possible undesirable effects:
The tablets must be kept in the original factory packaging, in a dry place protected from light, at a temperature not exceeding 25 °C (77 °F). Access by children must be categorically prevented.

